This is the authors' abstract. We don't add key points for this paper.
We report the first isolation of Candida auris in Greece from a sputum culture of a cystic fibrosis patient in their 20s under posaconazole treatment. The pathogen was identified as C. duobushaemulonii by VITEK2YST, but as C. auris by MALDI-TOF MS. This case underscores the need for species-level identification of all non-albicans Candida (NAC) isolates from cystic fibrosis patients and patients with predisposing factors to fungal infection.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Stathi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: